BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37620794)

  • 1. Desmocollin-1 is associated with pro-metastatic phenotype of luminal A breast cancer cells and is modulated by parthenolide.
    Lapcik P; Sulc P; Janacova L; Jilkova K; Potesil D; Bouchalova P; Müller P; Bouchal P
    Cell Mol Biol Lett; 2023 Aug; 28(1):68. PubMed ID: 37620794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A complex of cadherin 17 with desmocollin 1 and p120-catenin regulates colorectal cancer migration and invasion according to the cell phenotype.
    Bartolomé RA; Pintado-Berninches L; Martín-Regalado Á; Robles J; Calvo-López T; Ortega-Zapero M; Llorente-Sáez C; Boukich I; Fernandez-Aceñero MJ; Casal JI
    J Exp Clin Cancer Res; 2024 Jan; 43(1):31. PubMed ID: 38263178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics Identification and Validation of Desmocollin-1 and Catechol-O-Methyltransferase as Proteins Associated with Breast Cancer Cell Migration and Metastasis.
    Faktor J; Knopfova L; Lapcik P; Janacova L; Paralova V; Bouchalova P; Muller P; Benes P; Bouchal P
    Proteomics; 2019 Nov; 19(21-22):e1900073. PubMed ID: 31617665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parthenolide reduces metastasis by inhibition of vimentin expression and induces apoptosis by suppression elongation factor α - 1 expression.
    Jafari N; Nazeri S; Enferadi ST
    Phytomedicine; 2018 Mar; 41():67-73. PubMed ID: 29519321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nuclear factor kappa B inhibitor parthenolide restores ICI 182,780 (Faslodex; fulvestrant)-induced apoptosis in antiestrogen-resistant breast cancer cells.
    Riggins RB; Zwart A; Nehra R; Clarke R
    Mol Cancer Ther; 2005 Jan; 4(1):33-41. PubMed ID: 15657351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catechol-O-methyl transferase suppresses cell invasion and interplays with MET signaling in estrogen dependent breast cancer.
    Janacova L; Stenckova M; Lapcik P; Hrachovinova S; Bouchalova P; Potesil D; Hrstka R; Müller P; Bouchal P
    Sci Rep; 2023 Jan; 13(1):1285. PubMed ID: 36690660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 17beta-hydroxysteroid dehydrogenase type 1 modulates breast cancer protein profile and impacts cell migration.
    Aka JA; Zerradi M; Houle F; Huot J; Lin SX
    Breast Cancer Res; 2012 Jun; 14(3):R92. PubMed ID: 22691413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower DSC1 expression is related to the poor differentiation and prognosis of head and neck squamous cell carcinoma (HNSCC).
    Wang Y; Chen C; Wang X; Jin F; Liu Y; Liu H; Li T; Fu J
    J Cancer Res Clin Oncol; 2016 Dec; 142(12):2461-2468. PubMed ID: 27601166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic impact of desmocollins in human lung cancer.
    Cui T; Chen Y; Yang L; Mireskandari M; Knösel T; Zhang Q; Kohler LH; Kunze A; Presselt N; Petersen I
    J Clin Pathol; 2012 Dec; 65(12):1100-6. PubMed ID: 23002285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of desmocollin 1-3 and homeobox genes PITX1 and CDX2 are associated with tumor progression and survival in colorectal carcinoma.
    Knösel T; Chen Y; Hotovy S; Settmacher U; Altendorf-Hofmann A; Petersen I
    Int J Colorectal Dis; 2012 Nov; 27(11):1391-9. PubMed ID: 22438068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmocollin switching in colorectal cancer.
    Khan K; Hardy R; Haq A; Ogunbiyi O; Morton D; Chidgey M
    Br J Cancer; 2006 Nov; 95(10):1367-70. PubMed ID: 17088906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic Analysis of Epithelial to Mesenchymal Transition (EMT) Reveals Cross-talk between SNAIL and HDAC1 Proteins in Breast Cancer Cells.
    Palma Cde S; Grassi ML; Thomé CH; Ferreira GA; Albuquerque D; Pinto MT; Ferreira Melo FU; Kashima S; Covas DT; Pitteri SJ; Faça VM
    Mol Cell Proteomics; 2016 Mar; 15(3):906-17. PubMed ID: 26764010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of desmocollin synthesis in human epithelia: immunolocalization of desmocollins 1 and 3 in special epithelia and in cultured cells.
    Nuber UA; Schäfer S; Stehr S; Rackwitz HR; Franke WW
    Eur J Cell Biol; 1996 Sep; 71(1):1-13. PubMed ID: 8884173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RIP3 overexpression sensitizes human breast cancer cells to parthenolide in vitro via intracellular ROS accumulation.
    Lu C; Zhou LY; Xu HJ; Chen XY; Tong ZS; Liu XD; Jia YS; Chen Y
    Acta Pharmacol Sin; 2014 Jul; 35(7):929-36. PubMed ID: 24909514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell context-dependent activities of parthenolide in primary and metastatic melanoma cells.
    Czyz M; Lesiak-Mieczkowska K; Koprowska K; Szulawska-Mroczek A; Wozniak M
    Br J Pharmacol; 2010 Jul; 160(5):1144-57. PubMed ID: 20590608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-Dimensional-PAGE Coupled with nLC-MS/MS-Based Identification of Differentially Expressed Proteins and Tumorigenic Pathways in MCF7 Breast Cancer Cells Transfected for JTB Protein Silencing.
    Jayathirtha M; Jayaweera T; Whitham D; Sullivan I; Petre BA; Darie CC; Neagu AN
    Molecules; 2023 Nov; 28(22):. PubMed ID: 38005222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parthenolide and costunolide reduce microtentacles and tumor cell attachment by selectively targeting detyrosinated tubulin independent from NF-κB inhibition.
    Whipple RA; Vitolo MI; Boggs AE; Charpentier MS; Thompson K; Martin SS
    Breast Cancer Res; 2013; 15(5):R83. PubMed ID: 24028602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parthenolide induces MITF-M downregulation and senescence in patient-derived MITF-M(high) melanoma cell populations.
    Hartman ML; Talar B; Sztiller-Sikorska M; Nejc D; Czyz M
    Oncotarget; 2016 Feb; 7(8):9026-40. PubMed ID: 26824319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desmocollin 3 has a tumor suppressive activity through inhibition of AKT pathway in colorectal cancer.
    Cui T; Yang L; Ma Y; Petersen I; Chen Y
    Exp Cell Res; 2019 May; 378(2):124-130. PubMed ID: 30857973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the effects of overexpression of jumping translocation breakpoint (JTB) protein in MCF7 cells for potential use as a biomarker in breast cancer.
    Jayathirtha M; Neagu AN; Whitham D; Alwine S; Darie CC
    Am J Cancer Res; 2022; 12(4):1784-1823. PubMed ID: 35530281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.